Bristol-Myers Squibb Company (BMY) BidaskScore is downgraded to Bought

Bristol-Myers Squibb Co.

The BidaskScore of Bristol-Myers Squibb Company BMYBMY shows that the shares of the company are now BMYStrongly Bought Bought by investors.

The BidaskScore of the PharmaceuticalsPharmaceuticals shows that the sector is PharmaceuticalsStrongly Bought Held since April 21.

Here are the BidAskScore of other related companies in the Pharmaceuticals sector:

Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Bristol-Myers Squibb Co.

Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.